<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liang J</submitter><funding>National Key R&amp;D Program of China</funding><funding>National Natural Science Foundation of China</funding><funding>Beijing Science and Technology Planning Project</funding><pagination>157</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10691013</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Acute-on-chronic liver failure (ACLF) is a refractory disease with high mortality, which is characterized by a pathophysiological process of inflammation-related dysfunction of energy metabolism. Jieduan-Niwan formula (JDNWF) is a eutherapeutic Chinese medicine formula for ACLF. However, the intrinsic mechanism of its anti-ACLF effect still need to be studied systematically.&lt;h4>Purpose&lt;/h4>This study aimed to investigate the mechanism of JDNWF against ACLF based on altered substance metabolic profile in ACLF the expression levels of related molecules.&lt;h4>Materials and methods&lt;/h4>The chemical characteristics of JDNWF were characterized using ultra performance liquid chromatography (UPLC) coupled with triple quadrupole mass spectrometry. Wistar rats subjected to a long-te</pubmed_abstract><journal>Chinese medicine</journal><pubmed_title>Liver metabolomics reveals potential mechanism of Jieduan-Niwan formula against acute-on-chronic liver failure (ACLF) by improving mitochondrial damage and TCA cycle.</pubmed_title><pmcid>PMC10691013</pmcid><funding_grant_id>82074237</funding_grant_id><funding_grant_id>2018YFC1704102</funding_grant_id><funding_grant_id>JJ-2020-51</funding_grant_id><pubmed_authors>Ma R</pubmed_authors><pubmed_authors>Liang J</pubmed_authors><pubmed_authors>Gao Y</pubmed_authors><pubmed_authors>Wei X</pubmed_authors><pubmed_authors>Du Y</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Hou W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Liver metabolomics reveals potential mechanism of Jieduan-Niwan formula against acute-on-chronic liver failure (ACLF) by improving mitochondrial damage and TCA cycle.</name><description>&lt;h4>Background&lt;/h4>Acute-on-chronic liver failure (ACLF) is a refractory disease with high mortality, which is characterized by a pathophysiological process of inflammation-related dysfunction of energy metabolism. Jieduan-Niwan formula (JDNWF) is a eutherapeutic Chinese medicine formula for ACLF. However, the intrinsic mechanism of its anti-ACLF effect still need to be studied systematically.&lt;h4>Purpose&lt;/h4>This study aimed to investigate the mechanism of JDNWF against ACLF based on altered substance metabolic profile in ACLF the expression levels of related molecules.&lt;h4>Materials and methods&lt;/h4>The chemical characteristics of JDNWF were characterized using ultra performance liquid chromatography (UPLC) coupled with triple quadrupole mass spectrometry. Wistar rats subjected to a long-te</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-05T11:45:12.471Z</modification><creation>2025-04-05T11:45:12.471Z</creation></dates><accession>S-EPMC10691013</accession><cross_references><pubmed>38037150</pubmed><doi>10.1186/s13020-023-00858-x</doi></cross_references></HashMap>